Zobrazeno 1 - 10
of 33
pro vyhledávání: '"J. L. Claghorn"'
Publikováno v:
Acta psychiatrica Scandinavica. 87(5)
To compare the safety and efficacy of paroxetine (n = 167) and placebo (n = 169), data from 4 centres using the same protocol were pooled. A double-blind parallel group design was used, with therapy lasting 6 weeks. Significant differences between pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73fde581d3bfe94a604d8b589b308810
https://pubmed.ncbi.nlm.nih.gov/7625185
https://pubmed.ncbi.nlm.nih.gov/7625185
Autor:
L E Hollister, J L Claghorn
Publikováno v:
Annual review of pharmacology and toxicology. 33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a0546862c43ce0e67337c08a48472d4
https://pubmed.ncbi.nlm.nih.gov/8494338
https://pubmed.ncbi.nlm.nih.gov/8494338
Publikováno v:
The Journal of clinical psychiatry. 53(12)
Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI). The present study assessed the efficacy and tolerability of paroxetine against placebo in depressed outpatients.A double-blind, parallel-group study was undertaken in four stan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4cae542dee412854c9a20a1841aa388e
https://pubmed.ncbi.nlm.nih.gov/7852258
https://pubmed.ncbi.nlm.nih.gov/7852258
Autor:
J L, Claghorn
Publikováno v:
The Journal of clinical psychiatry.
Considerable research shows that serotonin dysfunction is implicated in major depression. Paroxetine is an investigational antidepressant that appears to act by selectively blocking neuronal serotonin uptake. Seventy-two outpatients with moderate-to-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d609224a882323d5bd6bd7e5bf0f1e10
https://pubmed.ncbi.nlm.nih.gov/1531821
https://pubmed.ncbi.nlm.nih.gov/1531821
Autor:
C K, Cohn, R, Shrivastava, J, Mendels, J B, Cohn, L F, Fabre, J L, Claghorn, E C, Dessain, T M, Itil, A, Lautin
Publikováno v:
The Journal of clinical psychiatry. 51
Two hundred forty-one elderly depressed patients entered the 8-week, double-blind phase of this parallel-group, multicenter study; 161 patients were randomized to receive sertraline (50-200 mg/day) and 80 were randomized to receive amitriptyline (50-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5b6227f388fb8ada924c70f864ea6ae8
https://pubmed.ncbi.nlm.nih.gov/2258379
https://pubmed.ncbi.nlm.nih.gov/2258379
Publikováno v:
Acta Psychiatrica Scandinavica. 67:307-314
The effect of relaxation training, utilizing EMG biofeedback, on platelet monoamine oxidase (MAO) activity was examined in patients with a history of chronic anxiety. Anxiety scores and MAO activity were significantly lowered after 4 weeks of therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1ee8c6c04c94cdcfb8b8832b8a5ab9
https://doi.org/10.1111/j.1600-0447.1983.tb00347.x
https://doi.org/10.1111/j.1600-0447.1983.tb00347.x
Autor:
J. L. Claghorn
Publikováno v:
JAMA: The Journal of the American Medical Association. 196:1089-1091
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf0f64b4d4a71ebce84ba9954aaacde7
https://doi.org/10.1001/jama.196.12.1089
https://doi.org/10.1001/jama.196.12.1089
Publikováno v:
Acta psychiatrica Scandinavica. 63(3)
Levels of platelet monoamine oxidase activity, state anxiety and trait anxiety were quantified twice in 20 drug-free subjects with generalized anxiety and an equal number of healthy drug-free controls at 4-week intervals. Fiften subjects in each grou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::592417aa888fa302ab4fc9fb5f0850ac
https://pubmed.ncbi.nlm.nih.gov/7234479
https://pubmed.ncbi.nlm.nih.gov/7234479
An overview of seventeen years of experience with dothiepin in the treatment of depression in Europe
Autor:
B J, Goldstein, J L, Claghorn
Publikováno v:
The Journal of clinical psychiatry. 41(12 Pt 2)
The European clinical experience with dothiepin since 1962 indicates that it is efficacious in the treatment of depression (neurotic, psychotic, and with concomitant anxiety) in dose of 75-200 mg/day. The side effects profile is similar to the tricyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44a700aefd6d94567ebcbf50a9c7da85
https://pubmed.ncbi.nlm.nih.gov/7440528
https://pubmed.ncbi.nlm.nih.gov/7440528
Autor:
J L, Claghorn
Publikováno v:
The Journal of clinical psychiatry. 46(8 Pt 2)
The literature concerning the pharmacokinetics, pharmacodynamics, receptor physiology, and clinical use of molindone is reviewed. Unanswered questions about the drug are addressed. Although molindone is reputed to have a short half-life (1.5 hours),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d84eecb3288f42e25923875f066b2c94
https://pubmed.ncbi.nlm.nih.gov/3894340
https://pubmed.ncbi.nlm.nih.gov/3894340